INS and diabetes mellitus: The NOD female progressors had similar levels of glycemia (Figure 2C) than the non-progressors but to our surprise the progressors exhibited higher fasting as well as glucose-stimulated plasma insulin levels (2-way ANOVA p = 0.025 for diabetes progression) (Figure 2D) despite the fact that no body weight differences were evident between progressors and non-progressors at 10 weeks of age (Figure 2E).